Finance

Lists
000520:KRX
Samil Pharmaceutical Co Ltd
8 230,00 KRW
+0,61%
(+50,00) 1D
19-окт., 15:30:25 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000520...
Open
8 100 KRW
High
8 350 KRW
Low
7 910 KRW
Mkt. cap
178,52 млд
Avg. vol.
88,47 миң
Volume
62,99 миң
52-wk high
12 860 KRW
52-wk low
5 500 KRW
EPS
-1 768 KRW
Shares outstanding
21,69 млн
No. of employees
583
Open
8 100 KRW
High
8 350 KRW
Low
7 910 KRW
Mkt. cap
178,52 млд
Avg. vol.
88,47 миң
Volume
62,99 миң
52-wk high
12 860 KRW
52-wk low
5 500 KRW
EPS
-1 768 KRW
Shares outstanding
21,69 млн
No. of employees
583
News stories
From web sources and news partners
About Samil Pharmaceutical Co Ltd
CEOSeung-Bum Huh
Employees583
Founded1947
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
51,18 млд
53,00 млд
52,55 млд
50,60 млд
Cost of goods sold
32,69 млд
33,56 млд
35,46 млд
31,67 млд
Cost of revenue
32,69 млд
33,56 млд
35,46 млд
31,67 млд
Research and development expenses
2,12 млд
1,95 млд
1,54 млд
1,11 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,72 млд
23,40 млд
21,31 млд
21,62 млд
Operating expense
23,65 млд
29,72 млд
25,47 млд
25,27 млд
Total operating expenses
56,34 млд
63,27 млд
60,93 млд
56,94 млд
Operating income
-5,17 млд
-10,27 млд
-8,39 млд
-6,34 млд
Other non operating income
-150,57 млн
-86,20 млн
61,42 млн
265,18 млн
EBT including unusual items
-7,70 млд
-12,75 млд
-10,62 млд
-8,50 млд
EBT excluding unusual items
-7,70 млд
-12,52 млд
-10,61 млд
-8,27 млд
Income tax expense
225,00 млн
-1,59 млд
209,00 млн
-805,73 млн
Effective tax rate
-2,92%
12,45%
-1,97%
9,48%
Other operating expenses
58,40 млн
224,61 млн
127,20 млн
242,60 млн
Net income
-7,93 млд
-11,16 млд
-10,83 млд
-7,69 млд
Net profit margin
-15,49%
-21,06%
-20,62%
-15,20%
Earnings per share
-
-
-
-
Interest and investment income
12,05 млн
11,10 млн
10,33 млн
13,76 млн
Interest expense
-2,29 млд
-2,17 млд
-2,14 млд
-2,23 млд
Net interest expenses
-2,27 млд
-2,16 млд
-2,13 млд
-2,22 млд
Depreciation and amortization charges
2,07 млд
2,17 млд
2,12 млд
2,01 млд
EBITDA
-1,91 млд
-7,97 млд
-4,92 млд
-2,95 млд
Gain or loss from assets sale
-
-1,14 млн
18,43 млн
228,07 млн
AI content may include mistakes. Learn more
Google колдонмолору